Patents by Inventor Matthias Hoekstra

Matthias Hoekstra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070298121
    Abstract: A synthesized composition containing zinc ions, calcium ions, rubidium ions and/or potassium ions in a pharmaceutically acceptable carrier, which, when applied to an open wound, effectively modulates the activity of at least MMP-2 and/or MMP-9 in the wound. A method for treatment of wounds is disclosed.
    Type: Application
    Filed: July 17, 2007
    Publication date: December 27, 2007
    Inventors: Stephen Monroe, Matthias Hoekstra
  • Publication number: 20070009611
    Abstract: A synthesized composition containing zinc ions, calcium ions, rubidium ions and/or potassium ions in a pharmaceutically acceptable carrier, which, when applied to an open wound, effectively modulates-the activity of at least MMP-2 and/or MMP-9 in the wound. A method for treatment of wounds is disclosed.
    Type: Application
    Filed: September 20, 2006
    Publication date: January 11, 2007
    Inventors: Stephen Monroe, Matthias Hoekstra
  • Publication number: 20060105017
    Abstract: A method for treatment of wounds associated with the insertion of a medical implant, wherein an inorganic therapeutic agent containing potassium, rubidium, calcium and zinc cations is applied to the wound site on a silicone or bioabsorbable membrane. The therapeutic composition is provided in a long lasting, timed delivery formulation to improve the efficacy of the therapeutic agent. The membrane may contain a micro-texture to further control delivery of the therapeutic agent to the wound site.
    Type: Application
    Filed: June 22, 2005
    Publication date: May 18, 2006
    Applicant: GREYSTONE MEDICAL GROUP, INC.
    Inventors: Xaverius Walboomers, Matthias Hoekstra, J. Jansen
  • Publication number: 20060029682
    Abstract: A synthesized composition containing zinc ions, calcium ions, rubidium ions and/or potassium ions in a pharmaceutically acceptable carrier, which, when applied to an open wound, effectively modulates the activity of at least MMP-2 and/or MMP-9 in the wound. A method for treatment of wounds is disclosed.
    Type: Application
    Filed: March 15, 2005
    Publication date: February 9, 2006
    Inventors: Stephen Monroe, Matthias Hoekstra